Question · asked by 1 review
Benzodiazepines vs phenobarbital (as active placebo): Acceptability
- Population
- patients with antipsychotic‐induced tardive dyskinesia
- Intervention
- Benzodiazepines
- Comparison
- phenobarbital (as active placebo)
- Outcome
- Acceptability
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Benzodiazepines vs phenobarbital (as active placebo) Acceptability of the treatment (measured by participants leaving the study early) · psychiatric patients (mainly schizophrenia) with antipsychotic‐induced tardive dyskinesia Benzodiazepines for antipsychotic‐induced tardive dyskinesia (2018) · Cochrane Headline outcomes only | no estimate extracted | 1 study · 21 participants | Very low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Benzodiazepines for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Benzodiazepines vs placebo · patients with antipsychotic‐induced tardive dyskinesia · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.